Please use this identifier to cite or link to this item: http://dx.doi.org/10.18419/opus-1798
Authors: Hauber, Wolfgang
Andersen, Ragna
Title: The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Issue Date: 1993
metadata.ubs.publikation.typ: Zeitschriftenartikel
metadata.ubs.publikation.source: Naunyn-Schmiedeberg's Archives of Pharmacology 348 (1993), S. 486-490. URL http://dx.doi.org./10.1007/BF00173207
URI: http://nbn-resolving.de/urn:nbn:de:bsz:93-opus-39746
http://elib.uni-stuttgart.de/handle/11682/1815
http://dx.doi.org/10.18419/opus-1798
Abstract: The effects of the non-NMDA glutamate receptor antagonist GYKI 52466 (2.4 and 4.8 mg/kg, i.p.) on spontaneous locomotor activity and haloperidol-induced catalepsy (0.5 mg/kg, i.p.) were assessed in naive rats and in rats pretreated with the NMDA antagonist dizocilpine (0.08 mg/kg, i.p.). GYKI 52466 given alone did not alter locomotor activity and haloperidol-induced catalepsy, but significantly antagonized the dizocilpine-induced locomotor stimulation and counteracted the anti-cataleptic effects of dizocilpine on haloperidol-induced catalepsy. Thus blockade of non-NMDA glutamate receptors antagonized the behavioural stimulant effects of a NMDA receptor blockade.
Appears in Collections:04 Fakultät Energie-, Verfahrens- und Biotechnik

Files in This Item:
File Description SizeFormat 
hau5.pdf559,12 kBAdobe PDFView/Open


Items in OPUS are protected by copyright, with all rights reserved, unless otherwise indicated.